|
|
| A Full-Service Solution Partner Disrupting the Outsourcing Paradigm | inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for its’ clients who have experienced the progressive degradation of today’s outsourcing options. Contact them. |
|
|
|
|
A conversation with Simon Capewell, AstraZeneca | The company's packing in the latest technology at its APICOM facility in Dublin. A key feature is more effective and timely use of process data. |
|
|
|
|
|
| Direct-To-Patient RTSM Solution | White Paper | By Bart Nicholson, Signant Health | Explore modern decentralized trials that bring the supply chain into the patient experience. and including the pros and cons of direct-to-patient models. |
|
|
|
|
.png){kind=logo}
